A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT04974398 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04974398
- Sponsor
- Akeso
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-16
- Primary completion
- 2026-02-23
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.